The maker of an unproven drug intended to prevent premature births says it will voluntarily remove the product from the U.S., after regulators signaled plans to follow through on a long-delayed effort to force it from the market.
The announcement late Tuesday from Covis Pharma comes roughly four years after the company’s drug, Makena, failed to show a benefit in helping mothers carry pregnancies to term.
